NCT03987386View on ClinicalTrials.gov

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

May 30, 2019

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
Interventions
RADIATION

Hypofractionated Radiation Therapy

Undergo hypofractionated radiation therapy

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

RADIATION

Radiation Therapy

Undergo conventional radiation therapy

Trial Locations (3)

77030

M D Anderson Cancer Center, Houston

77478

MD Anderson in Sugar Land, Sugar Land

77573

MD Anderson League City, League City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03987386 - Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter